Home / Products / Antibiotics / CIXUP-CL
Click image to inspect pack details
Antibiotics Marketed by Aerochem Neutron

CIXUP-CL

Formulation Code AC-478
Commercial Status Active Product Information Available

Product Overview & Formulation Profile

Description

Cefixime 200 mg + Clavulanic Acid 125 mg Tablets

CIXUP-CL contains cefixime, an oral third-generation cephalosporin antibiotic, combined with clavulanic acid, a beta-lactamase inhibitor.

Cefixime acts by inhibiting bacterial cell-wall synthesis. Clavulanic acid inhibits certain beta-lactamase enzymes involved in bacterial resistance to beta-lactam antibiotics.

The combination brings together two distinct pharmacological actions. However, the addition of clavulanic acid does not necessarily improve cefixime activity against every resistant bacterial strain.

Treatment with CIXUP-CL should be based on the approved indication, clinical assessment and relevant bacterial susceptibility patterns. Antibiotic use must follow current prescribing guidance.

Composition: Cefixime 200 mg + Clavulanic Acid 125 mg
Dosage Form: Tablets
Packing: 10 x 6 Strip Pack

Prescription medicine. To be used under medical supervision.

Composition & Formulation Details

Features

  • Cephalosporin and beta-lactamase inhibitor combination: Contains cefixime 200 mg and clavulanic acid 125 mg.

  • Bacterial cell-wall inhibition: Cefixime interferes with bacterial cell-wall synthesis.

  • Beta-lactamase inhibition: Clavulanic acid inhibits certain beta-lactamase enzymes, although this does not establish clinical activity against every resistant organism.

  • Oral tablet formulation: Provides the two ingredients in a single fixed-dose tablet.

  • Clinical considerations: Selection should be guided by the authorised indication, bacterial susceptibility and responsible antibiotic prescribing.

Conditions

Therapeutic Indications — Label Verification Required

CIXUP-CL is an antibacterial fixed-dose combination containing cefixime and clavulanic acid.

Use is restricted to bacterial infections for which the exact combination is authorised and clinically appropriate.

Specific indications must be confirmed from the approved Indian product label before being displayed on the website.

Not indicated for viral infections.

Professional Product Enquiries

Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.

Product Information

Review verified active composition, strength, dosage form, and packaging details on this page.

View Specifications

Healthcare Professional Enquiry

Request formulation literature, technical specifications, or product communication from our commercial team.

Submit Product Enquiry

Commercial Supply Enquiry

Connect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.

Commercial Enquiry

Professional Product Information

This product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.

Product Enquiry

Request Formulation Details

Request information about CIXUP-CL for professional use.

Please enter the numeric sum to verify you are a human visitor.
Therapeutic Alternatives

Related Formulations

SULTAVIN Formulation
AEROCLAV -625 Formulation
AEROFLOX 200 Formulation
A.G 250 Formulation
Product Information

Need specifications for this formulation?

Request verified product information for professional use, or send a separate business enquiry for manufacturing or partnership discussions.

WhatsApp: +91 9512047000